Table 2 Top 20 diseases affected by EA stimulation at ST36 in lung
Diseases | p-value | Gene/Total objects |
|---|---|---|
Pathologic Processes | 7.75E-28 | 101/2642 |
Pulmonary Disease, Chronic Obstructive | 8.21E-26 | 57/881 |
Nutritional and Metabolic Diseases | 8.30E-25 | 105/3099 |
Metabolic Diseases | 4.00E-23 | 96/2765 |
Pathological Conditions, Signs and Symptoms | 6.83E-23 | 123/4334 |
Connective Tissue Diseases | 3.75E-21 | 82/2213 |
Rheumatic Diseases | 2.30E-20 | 67/1563 |
Lung Diseases, Obstructive | 6.69E-20 | 68/1640 |
Bacterial Infections and Mycoses | 7.73E-20 | 60/1293 |
Arthritis | 9.28E-20 | 68/1650 |
Arthritis, Rheumatoid | 1.83E-19 | 63/1446 |
Joint Diseases | 2.43E-19 | 68/1680 |
Infection | 2.11E-18 | 55/1171 |
Hypersensitivity | 3.60E-18 | 63/1535 |
Hypersensitivity, Immediate | 4.38E-18 | 59/1362 |
Wounds and Injuries | 6.15E-18 | 50/995 |
Cardiovascular Diseases | 8.12E-18 | 100/3520 |
Heart Diseases | 2.58E-16 | 56/1351 |
Vascular Diseases | 3.33E-16 | 91/3179 |
Fibrosis | 5.08E-16 | 33/475 |